Shattuck Labs (STTK)
(Delayed Data from NSDQ)
$2.28 USD
+0.05 (2.24%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $2.27 -0.01 (-0.44%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Shattuck Labs, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
STTK 2.28 +0.05(2.24%)
Will STTK be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for STTK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for STTK
Should You Buy Shattuck Labs, Inc. (STTK) After Golden Cross?
Shattuck Labs (STTK) Upgraded to Buy: What Does It Mean for the Stock?
STTK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Down -64.19% in 4 Weeks, Here's Why Shattuck Labs (STTK) Looks Ripe for a Turnaround
After Plunging -68.96% in 4 Weeks, Here's Why the Trend Might Reverse for Shattuck Labs (STTK)
STTK Discontinues Cancer Program, Plans Workforce Cut, Stock Falls
Other News for STTK
Is STTK ready to move higher? Golden Cross shows up after climbing 2.24%
Is STTK showing upside potential? Reversal New Highs Setup shows up after rallying 14.95%
The technical outlook for STTK is unchanged after it falls 9.35% on September 17
Shattuck Labs files to sell 105.27M shares of common stock for holders
Shattuck Labs files to sell 105.27M shares of common stock for holders